This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Today, a brief rundown of news from Madrigal Pharmaceuticals and Daiichi Sankyo, as well as updates from Johnson & Johnson, AC Immune and Novartis that you may have missed. Shares of Madrigal Pharmaceuticals fell by double digits on Thursday despite quarterly numbers for its liver disease drug Rezdiffra that again surpassed consensus estimates. Rezdiffra four ...

Johnson & Johnson on Wednesday announced plans to invest more than $1 billion in a next-generation manufacturing facility that will produce advanced cell therapy technologies. The facility will be located in Montgomery County, Pennsylvania, and Johnson & Johnson said the move will expand its U.S. manufacturing capacity along with its pipeline of transformational medicines for cancer, immune-mediated and neurological diseases.Johnson & Johnson added that the facility will have cutting-edge manufacturing proc ...